Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 29;14(2):798-805.
doi: 10.21037/jgo-23-134.

The Frailty Index and colon cancer: a 2-sample Mendelian-randomization study

Lingling Gao #  1 , Xiaoling Di #  2 , Lulu Gao  3 , Zhanhui Liu  4 , Fengping Hu  5
Affiliations

The Frailty Index and colon cancer: a 2-sample Mendelian-randomization study

Lingling Gao et al. J Gastrointest Oncol. .

Abstract

Background: Frailty is closely related to cancer. Previous research has shown that cancer patients are prone to frailty, and frailty increases the risk of adverse outcomes in cancer patients. However, it is unclear whether frailty increases the risk of cancer. This 2-sample Mendelian-randomization (MR) study sought to analyze the relationship between frailty and the risk of colon cancer.

Methods: The database was extracted from the Medical Research Council Integrative Epidemiology Unit (MRC-IEU) in 2021. The genome-wide association study (GWAS) data related to colon cancer was obtained from the GWAS website (http://gwas.mrcieu.ac.uk/datasets), involving 462,933 individuals' gene information. Single-nucleotide polymorphisms (SNPs) were defined as the instrumental variables (IVs). The SNPs closely associated with the Frailty Index at a genome-wide significance level were selected. To further screen the IVs, we selected the confounding factors using the PhenoScanner (http://www.phenoscanner.medschl.cam.ac.uk/phenoscanner). To estimate the causal effect of the Frailty Index on colon cancer, the MR-Egger regression, weighted median (WM1), inverse-variance weighted (IVW), and weight mode (WM2) methods were applied to calculate the SNP-frailty index and the SNP-cancer estimates. Cochran's Q statistic was used to estimate heterogeneity. The two-sample Mendelian randomization (TSMR) analysis was performed using the "TwoSampleMR" and "plyr" packages. All the statistical tests were 2-tailed, and a P value <0.05 was considered statistically significant.

Results: We selected 8 SNPs as the IVs. The results of the IVW analysis [odds ratio (OR) =0.995, 95% confidence interval (CI): 0.990-1.001, P=0.052] showed that the genetic changes in the Frailty Index were not statistically associated with the risk of colon cancer, and no significant heterogeneity between these 8 genes was observed (Q =7.382, P=0.184). The MR-Egger (OR =0.987, 95% CI: 0.945-1.031, P=0.581), WM1 (OR =0.995, 95% CI: 0.990-1.001, P=0.118), WM2 (OR =0.996, 95% CI: 0.988-1.004, P=0.356), and SM (OR =0.996, 95% CI: 0.987-1.005, P=0.449) results were also consistent with each other. The sensitivity analysis based on the leave-one-out method showed that the individual SNPs did not affect the robustness of the results.

Conclusions: Frailty might have no effect on the risk of colon cancer.

Keywords: 2-sample Mendelian-randomization study; Frailty; cancer; risk.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups.com/article/view/10.21037/jgo-23-134/coif). The authors have no conflicts of interest to declare

Figures

Figure 1
Figure 1
Scatter plots summarizing the results of the 5 MR analysis methods. MR, Mendelian-randomization. SNP, single-nucleotide polymorphism.
Figure 2
Figure 2
The associations between the Frailty Index and colon cancer based on the MR analysis. (A) Forest plots; (B) sensitivity-analysis plots. MR, Mendelian-randomization.
See this image and copyright information in PMC

References

    1. Komici K, Bencivenga L, Navani N, et al. Frailty in Patients With Lung Cancer: A Systematic Review and Meta-Analysis. Chest 2022;162:485-97. 10.1016/j.chest.2022.02.027 - DOI - PubMed
    1. Wang S, Yang T, Qiang W, et al. The prevalence of frailty among breast cancer patients: a systematic review and meta-analysis. Support Care Cancer 2022;30:2993-3006. 10.1007/s00520-021-06641-8 - DOI - PubMed
    1. Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004;59:255-63. 10.1093/gerona/59.3.M255 - DOI - PubMed
    1. Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013;14:392-7. 10.1016/j.jamda.2013.03.022 - DOI - PMC - PubMed
    1. Collard RM, Boter H, Schoevers RA, et al. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 2012;60:1487-92. 10.1111/j.1532-5415.2012.04054.x - DOI - PubMed